Lexington, MA, United States of America

Brandi Lynn Bailey

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brandi Lynn Bailey. Retrieved from https://idiyas.com/inventor/brandi-lynn-bailey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brandi Lynn Bailey: Innovator in Antibody Development

Introduction

Brandi Lynn Bailey is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work is recognized for its potential impact on treating various medical conditions.

Latest Patents

Brandi holds a patent titled "Anti-Vedolizumab Antibodies and Uses Thereof." This patent represents her innovative approach to creating antibodies that can be utilized in therapeutic applications. She has 1 patent to her name, showcasing her expertise and dedication to advancing medical science.

Career Highlights

Brandi is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Her role involves research and development, where she focuses on creating effective treatments for patients. Her work at Takeda highlights her commitment to improving healthcare outcomes through innovative solutions.

Collaborations

Brandi collaborates with her coworker, Julius Juarez, to further enhance their research efforts. Together, they work on projects that aim to push the boundaries of current medical treatments and explore new possibilities in antibody therapy.

Conclusion

Brandi Lynn Bailey is a dedicated inventor whose work in antibody development is paving the way for future medical advancements. Her contributions to the field are invaluable, and her ongoing research promises to make a significant impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…